Eagle Bay Advisors LLC Nautilus Biotechnology, Inc. Transaction History

Eagle Bay Advisors LLC

  • $170 Million
  • Q3 2024

A detailed history of Eagle Bay Advisors LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 337 shares of NAUT stock, worth $566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
337
Previous 337 -0.0%
Holding current value
$566
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 19, 2022
BUY
$2.64 - $4.84 $889 - $1,631
337 New
337 $907,000
Q1 2022

May 11, 2022
SELL
$3.5 - $5.3 $1,179 - $1,786
-337 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$6.14 - $10.1 $2,069 - $3,403
337 New
337 $2,000

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $209M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email